The first human percutaneous aorto-coronary bypass, called "VECTOR", was used to prevent coronary obstruction after transcatheter aortic valve replacement. The procedure was performed on a patient who was not suitable for lip treatment. The aim was to prevent blockage of the coronary arteries after the procedure. Grafts are first sewn with one end to the coronary arteries behind the affected area and with the other end to the aorta. The principle is to bring blood to insufficiently supplied parts of the heart muscle due to the narrowing of the coronary arteries. This will improve life prognosis by prolonging life and reducing the risk of heart attack. The quality of life will improve by eliminating the symptoms of the disease. Arterial and vein grafts are used to create the bypass, with vein grafts obtained endoscopically from the leg and arterial grafts such as the radial artery having a long-term patency of 90-95% at 10 years.[1]